Does OLANZAPINE Cause Agranulocytosis? 277 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 277 reports of Agranulocytosis have been filed in association with OLANZAPINE (Olanzapine). This represents 0.5% of all adverse event reports for OLANZAPINE.
277
Reports of Agranulocytosis with OLANZAPINE
0.5%
of all OLANZAPINE reports
16
Deaths
170
Hospitalizations
How Dangerous Is Agranulocytosis From OLANZAPINE?
Of the 277 reports, 16 (5.8%) resulted in death, 170 (61.4%) required hospitalization, and 93 (33.6%) were considered life-threatening.
Is Agranulocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 277 reports have been filed with the FAERS database.
What Other Side Effects Does OLANZAPINE Cause?
Drug ineffective (5,139)
Weight increased (3,588)
Off label use (3,256)
Toxicity to various agents (3,175)
Somnolence (2,612)
Sedation (2,130)
Suicide attempt (2,116)
Confusional state (1,898)
Condition aggravated (1,810)
Overdose (1,765)
What Other Drugs Cause Agranulocytosis?
CLOZAPINE (1,766)
CYCLOPHOSPHAMIDE (1,242)
RITUXIMAB (1,154)
SULFAMETHOXAZOLE\TRIMETHOPRIM (797)
PANTOPRAZOLE (599)
METHOTREXATE (550)
SODIUM (549)
EPIRUBICIN (491)
METAMIZOLE (438)
DOCETAXEL (436)
Which OLANZAPINE Alternatives Have Lower Agranulocytosis Risk?
OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE
OLANZAPINE vs OLAPARIB
OLANZAPINE vs OLARATUMAB
OLANZAPINE vs OLECLUMAB
OLANZAPINE vs OLIVE OIL\SOYBEAN OIL